UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 305

Sortiert nach

Subclinical atherosclerosis: what it is, what it means and what we can do about it

International journal of clinical practice (Esher), 2008-08, Vol.62 (8), p.1246-1254

Toth, P. P.

2008

Link zum Volltext

Verfügbarkeit prüfen

Peptides as therapeutics with enhanced bioactivity

Current medicinal chemistry, 2012-09, Vol.19 (26), p.4451

2012

Link zum Volltext

Verfügbarkeit prüfen

Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials

Pharmacological research, 2019-05, Vol.143, p.1-16

2019

Link zum Volltext

Verfügbarkeit prüfen

Subfractions and subpopulations of HDL: an update

Current medicinal chemistry, 2014-01, Vol.21 (25), p.2881

2014

Link zum Volltext

Verfügbarkeit prüfen

Gender differences in the battle against COVID‐19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes

International journal of clinical practice (Esher), 2021-02, Vol.75 (2), p.e13666-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Insulin resistance, small LDL particles, and risk for atherosclerotic disease

Current vascular pharmacology, 2014-01, Vol.12 (4), p.653

Toth, Peter P

2014

Link zum Volltext

Verfügbarkeit prüfen

Novel Therapeutic Targets for Managing Dyslipidemia

Trends in pharmacological sciences (Regular ed.), 2018-08, Vol.39 (8), p.733-747

2018

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein Subfractions in Patients with Acute Coronary Syndromes: Should we Reach Beyond LDL-C?

Current vascular pharmacology, 2019-01, Vol.17 (4), p.376

Toth, Peter P

2019

Link zum Volltext

Verfügbarkeit prüfen

Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps

Journal of clinical lipidology, 2017-09, Vol.11 (5), p.1152-1160.e2

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Drugs (New York, N.Y.), 2019-05, Vol.79 (7), p.751-766

2019

Link zum Volltext

Verfügbarkeit prüfen

Statin therapy and plasma coenzyme Q10 concentrations—A systematic review and meta-analysis of placebo-controlled trials

Pharmacological research, 2015-09, Vol.99, p.329-336

2015

Link zum Volltext

Verfügbarkeit prüfen

Hypertriglyceridemia in statin-treated US adults: the National Health and Nutrition Examination Survey

Journal of clinical lipidology, 2019-01, Vol.13 (1), p.100-108

2019

Link zum Volltext

Verfügbarkeit prüfen

A clinician's guide to statin drug-drug interactions

Journal of clinical lipidology, 2014-05, Vol.8 (3), p.S30-S46

2014

Link zum Volltext

Verfügbarkeit prüfen

Contemporary Management of Dyslipidemia

Drugs (New York, N.Y.), 2022-04, Vol.82 (5), p.559-576

2022

Link zum Volltext

Verfügbarkeit prüfen

Silver nanoparticles: aggregation behavior in biorelevant conditions and its impact on biological activity

International journal of nanomedicine, 2019-01, Vol.14, p.667-687

2019

Link zum Volltext

Verfügbarkeit prüfen

The potential role of statins in preeclampsia and dyslipidemia during gestation: a narrative review

Expert opinion on investigational drugs, 2018-05, Vol.27 (5), p.427-435

2018

Link zum Volltext

Verfügbarkeit prüfen

Atherogenic versus non-atherogenic lipoprotein profiles in healthy individuals. is there a need to change our approach to diagnosing dyslipidemia?

Current medicinal chemistry, 2014-01, Vol.21 (25), p.2892

2014

Link zum Volltext

Verfügbarkeit prüfen

Statins and new-onset diabetes

Current pharmaceutical design, 2014-01, Vol.20 (22), p.3657

2014

Link zum Volltext

Verfügbarkeit prüfen

Endosome Escape Strategies for Improving the Efficacy of Oligonucleotide Delivery Systems

Current medicinal chemistry, 2015-01, Vol.22 (29), p.3326

2015

Link zum Volltext

Verfügbarkeit prüfen

Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone

Clinical therapeutics, 2004-09, Vol.26 (9), p.1355-1367

2004

Link zum Volltext

Verfügbarkeit prüfen

Familial Hypercholesterolemias: Prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

Journal of clinical lipidology, 2011-06, Vol.5 (3), p.S9-S17

2011

Link zum Volltext

Verfügbarkeit prüfen

Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children

Expert opinion on pharmacotherapy, 2019-02, Vol.20 (3), p.241-244

2019

Link zum Volltext

Verfügbarkeit prüfen

Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system

Journal of clinical lipidology, 2016-07, Vol.10 (4), p.880-890

2016

Link zum Volltext

Verfügbarkeit prüfen

Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease

Alimentary pharmacology & therapeutics, 2011-10, Vol.34 (8), p.911-922

2011

Link zum Volltext

Verfügbarkeit prüfen

Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

Journal of clinical lipidology, 2011-05, Vol.5 (3), p.133-140

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 305

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(289)
Mit Volltextzugriff
(264)

Publikationsform

Artikel
(304)
Buchkapitel
(1)

Sprache

Englisch
(305)
Japanisch
(45)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Subclinical atherosclerosis: what it is, what it means and what we can do about it

Peptides as therapeutics with enhanced bioactivity

Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials

Subfractions and subpopulations of HDL: an update

Gender differences in the battle against COVID‐19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes

Insulin resistance, small LDL particles, and risk for atherosclerotic disease

Novel Therapeutic Targets for Managing Dyslipidemia

Lipoprotein Subfractions in Patients with Acute Coronary Syndromes: Should we Reach Beyond LDL-C?

Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps

Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Statin therapy and plasma coenzyme Q10 concentrations—A systematic review and meta-analysis of placebo-controlled trials

Hypertriglyceridemia in statin-treated US adults: the National Health and Nutrition Examination Survey

A clinician's guide to statin drug-drug interactions

Contemporary Management of Dyslipidemia

Silver nanoparticles: aggregation behavior in biorelevant conditions and its impact on biological activity

The potential role of statins in preeclampsia and dyslipidemia during gestation: a narrative review

Atherogenic versus non-atherogenic lipoprotein profiles in healthy individuals. is there a need to change our approach to diagnosing dyslipidemia?

Statins and new-onset diabetes

Endosome Escape Strategies for Improving the Efficacy of Oligonucleotide Delivery Systems

Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone

Familial Hypercholesterolemias: Prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children

Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system

Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease

Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

Aktive Filter

Suchergebnisse filtern